Five years of advances in electrochemical analysis of protein biomarkers in lung cancer: a systematic review
View abstract on PubMed
Summary
This summary is machine-generated.Early detection of lung cancer biomarkers is crucial. Electrochemical methods like biosensors offer faster, cheaper, and simpler ways to find these vital indicators in clinical samples.
Area Of Science
- Biomedical Engineering
- Analytical Chemistry
- Oncology
Background
- Lung cancer is a leading cause of cancer mortality globally.
- Early detection of specific biomarkers is essential for effective treatment and improved patient outcomes.
- Current diagnostic methods can be time-consuming, costly, and complex.
Purpose Of The Study
- To review and analyze electrochemical methods for lung cancer biomarker detection.
- To highlight the advantages of electrochemical techniques, including microfluidic devices and biosensors.
- To provide a comprehensive resource for researchers and clinicians in lung cancer diagnosis.
Main Methods
- Review of existing scientific literature on electrochemical detection of lung cancer biomarkers.
- Analysis of methodologies, including microfluidic devices and various biosensor platforms.
- Evaluation of reported detection limits and performance metrics.
Main Results
- Electrochemical methods demonstrate significant potential for rapid and sensitive lung cancer biomarker detection.
- Microfluidic devices and biosensors offer reduced assay complexity, time, and cost compared to traditional methods.
- A range of detection limits have been reported, showcasing the evolving capabilities of these techniques.
Conclusions
- Electrochemical approaches are highly promising for the early and accurate diagnosis of lung cancer.
- These methods can streamline the detection process, making it more accessible and efficient for clinical application.
- Further research and development in this area will significantly contribute to lung cancer management.

